Gender Differences in Autoimmune Diseases. Immune Mechanisms and Clinical Applications

Principles of Gender-Specific Medicine

Volumn , Issue , 2010, Pages 585-591

  Abdou, Nabih I ^a   Rider, Virginia ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b PITTSBURG STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870428328     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374271-1.00049-6     Document Type: Chapter

References (59)

1. Rider V, Abdou NI Gender differences in autoimmunity: molecular mechanisms for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol Rev 2001, 1:1009-1024.
2. Rider V, Abdou NI Sexual dimorphism and the immune system. Principles of Gender-Specific Medicine 2004, 1071-1081. Elsevier Academic Press, New York, NY. M.J. Legato (Ed.).
3. Lahita RG, Bradlow HL, Kunkel HG, Fishman J Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979, 22:1195-1198.
4. Gubbels Bupp MR, Jørgensen TN, Kotzin BL Identification of candidate genes that influence sex hormone-dependent disease phenotypes in mouse lupus. Genes Immun 2007, 10:47-56.
5. Jørgensen TN, Roper E, Thurman JM, Marrack P, Kotzin BL Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Genes Immun 2007, 8:653-662.
6. Hirano S, Furutama D, Hanafusa T Physiologically high concentrations of 17β-estradiol enhance NF-κB activity in human T cells. Am J Physiol 2007, 292:1465-1471.
7. Dunn SE, Ousman SS, Sobel RA, et al. Peroxisome proliferator-activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med 2007, 204:321-330.
8. Riggs BL, Hartman LC Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 2003, 348:618-629.
9. Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou NI Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 2001, 28:2644-2649.
10. Rider V, Foster RT, Evans MJ, Suenaga R, Abdou NI Gender differences in autoimmunity: estrogen increases calcineurin A2 expression in systemic lupus erythematosus. Clin Immunol Immunopathol 1998, 89:171-180.
11. Lambert KC, Curran EM, Judy BM, Milligan GN, Lubahn DB, Estes DM Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. J Immunol 2005, 175:5716-5723.
12. Bynoté KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZBxNZW)F1 mice. Genes Immun 2008, 10:137-152.
13. Gustafsson JA Estrogen receptor β - a new dimension in estrogen mechanism of action. J Endocrinol 1999, 163:379-383.
14. Deroo BJ, Korach KS Estrogen receptors and human disease. J Clin Invest 2006, 116:561-570.
15. Harris HA Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 2007, 21:1-13.
16. Imamov O, Shim GJ, Warner M, Gustafsson JA Estrogen receptor beta in health and disease. Biol Reprod 2005, 73:866-871.
17. Harris H. Estrogen receptor beta: a new target for anti-inflammatory therapy? Arthritis Rheumatol 2005;10, (Abstr.).
18. Cvoro A, Tatomer D, Tee MK, Zogovic T, Harris HA, Leitman DC Selective estrogen receptor-β agonists repress transcription of proinflammatory genes. J Immunol 2008, 180:630-636.
19. Sagawa A, Abdou NI Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. J Clin Invest 1978, 62:789-796.
20. Sagawa A, Abdou NI Suppressor cell antibody in systemic lupus erythematosus. Possible mechanisms for suppressor cell dysfunction. J Clin Immunol 1979, 63:536-543.
21. Valencia X, Yarboro C, Illei G, Lipsky PE Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
22. Polanczyk M, Hopke C, Huan J, Vandenbark AA, Offner H Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 2005, 170:85-92.
23. Abdou NI, Rider V, Greenwell C, Li X, Kimler BF Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. Clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. J Rheumatol 2008, 35:797-803.
24. Polanczyk MJ, Carson BD, Subramanian S, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004, 173:2227-2230.
25. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
26. Singh RP, La Cava A, Wong M, Ebling F, Hahn BH CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression. J Immunol 2007, 178:7649-7657.
27. Mor G, Sapi E, Abrahams VM, et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 2003, 170:114-122.
28. Subramanian M, Shaha C Up-regulation of Bcl-2 through ERK phosphorylation is associated with human macrophage survival in an estrogen microenvironment. J Immunol 2007, 179:2330-2338.
29. Evans M, MacLaughlin S, Marvin RD, Abdou NI Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-α production in SLE but not in normal cultures. Clin Immunol Immunopathol 1997, 82:258-262.
30. Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 2000, 85:1648-1657.
31. Paharkova-Vatchkova V, Maldonado R, Kovats S Estrogen preferentially promotes the differentiation of CD11c+ CD11b (intermediate) dendritic cells from bone marrow precursors. J Immunol 2004, 172:1426-1436.
32. Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 2008, 180:1423-1431.
33. Carreras E, Turner S, Paharkova-Vatchkova V, et al. Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. J Immunol 2008, 180:727-738.
34. Hughes GC, Thomas S, Li C, Kaja MK, Clark EA Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol 2008, 180:2029-2033.
35. Berghöfer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H TLR7 ligand induce higher INF-α production in females. J Immunol 2006, 177:2088-2096.
36. Mok MY, Ip WK, Lau CS, Lo Y, Wong WH, Lau YL Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus. J Rheumatol 2007, 34:1270-1276.
37. Methe H, Kim JO, Kofler S, Nabauer M, Weis M Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler Thromb Vasc Biol 2005, 25:1439-1445.
38. Cutolo M, Capellino S, Sulli A, et al. Estrogens and immune diseases. Ann N Y Acad Sci 2006, 1089:538-547.
39. Castagnetta L, Granata OM, Traina A, et al. Role for sex steroids in autoimmune diseases. A working hypothesis and supporting data. Ann N Y Acad Sci 2002, 966:193-203.
40. Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
41. Castagnetta LA, Carruba G, Granata OM, et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003, 30:2597-2605.
42. Cutolo M Sex hormone adjuvant therapy in rheumatoid arthritis. Rheum Dis Clin N Am 2000, 26:881-895.
43. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraception in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2550-2558.
44. Sánchez-Guerrero J, Uribe AG, Jiménez-Santana L, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2539-2549.
45. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005, 142:953-962.
46. Abdou NI Is it safe for lupus patients to take estrogen? It depends. J Clin Rheumatol 2007, 13:1.
47. Jungers P, Dougados M, Pélissier C, et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982, 25:618-623.
48. Suenaga R, Evans MJ, Mitamura K, Rider V, Abdou NI Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J Rheumatol 1998, 25:1305-1312.
49. Suenaga R, Rider V, Evans MJ, Abdou NI In vitro-activated T cells from SLE patients and normal donors express estrogen receptor alpha proteins which bind to the human estrogen response element. Lupus 2001, 10:116-122.
50. Rider V, Li X, Peterson G, Dawson J, Kimler BF, Abdou NI Differential expression of estrogen receptors in women with systemic lupus erythematosus. J Rheumatol 2006, 33:1093-1101.
51. Rider V, Abdou NI Hormones: epigenetic contributors to gender biased autoimmunity. Epigenetics in Autoimmune Diseases 2009, 310-336. Wiley, London. M. Zouali (Ed.).
52. Itoh Y, Hayashi H, Miyazawa K, et al. 17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalpha. J Immunol 2007, 178:3059-3066.
53. Shim GJ, Warner M, Kim HJ, et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren's syndrome. Proc Natl Acad Sci 2004, 101:12628-12633.
54. Ishimaru N, Arakaki R, Watanabe M, Kobayashi M, Miyazaki K, Hayashi Y Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background. Am J Pathol 2003, 163:1481-1490.
55. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248-250.
56. Sinha S, Kaler LJ, Proctor TM, Teuscher C, Vandenbark AA, Offner H IL-13 mediated gender difference in susceptibility to autoimmune encephalomyelitis. J Immunol 2008, 180:2679-2685.
57. Tadokoro CE, Shakhar G, Shen S, et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 2006, 203:505-511.
58. Abdou NI, Lisak RP, Zweiman B, Abrahamsohn I, Penn AS The thymus in myasthenia gravis: evidence of altered cell population. N Engl J Med 1974, 291:1271-1278.
59. Nancy P, Berrih-Aknin S Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology 2005, 146:2345-2353.